Code Against Cancer’s “ONCOdecalogue of Emotions” Receives Acclaim at PTPO Conference

Topic:

At the PTPO conference in Lublin, the latest publication of the “ONCOdecalogue” series received vast acclaim and appreciation from Poland’s top psycho-oncologists and oncologists. This conference, held to celebrate PTPO’s 30th anniversary, provided a prestigious platform for Code Against Cancer to showcase its impactful initiative.

About ONCOdecalogue of Emotions and Code Against Cancer:

Ardigen’s CODE AGAINST CANCER initiative aims to support oncology patients. With that in mind, the therapeutic fairy tale book “ONCOdecalogue of Emotions” was designed. It has successfully provided comfort and understanding to young patients, their families, and a wider audience alike through its usage during psycho-oncology workshops and therapy sessions.

Special Thanks to All Involved:

Seeing how a simple initiative can impact other people’s lives is uplifting. We are grateful to the Ardigen and Code Against Cancer communities for partaking in such commendable initiatives. We also would like to thank the lead consultant of our project and past president of PTPO, prof. Marzena Samardakiewicz.

About PTPO:

The Polish Psychooncological Society (PTPO) was established in 1992. The Society has about 100 members who in their professional activity come into contact with chronically and incurably ill people.

In addition to doctors of various specialties (psychiatrists, oncologists, gynecologists, surgeons, internists, general practitioners, etc.) and nurses, the Society is co-founded by psychologists, educators, sociologists, clergy and NGO volunteers. These people, understanding that proper treatment is not only about prolonging life, but also about ensuring its quality, strive to ensure the development, popularization and implementation of an integrated model of care.

You might be also interested in:

The role of AI CROs in the next wave of biopharma transformation)
AI CROs and the Pharma Shift: The Next Wave of Drug Discovery Innovation
AI hit-to-lead optimization for drug discovery
AI brain neurological diseases
Uncovering novel targets and approaches to treating neurological diseases

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!